Literature DB >> 19328583

Endothelin-receptor antagonist/N-acetylcysteine combination in type 1 hepatorenal syndrome.

Hassane Izzedine, Rania Kheder-Elfekih, Gilbert Deray, Dominique Thabut.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19328583     DOI： 10.1016/j.jhep.2009.02.002

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

Review 1.  Current Medical Treatment for Alcohol-Associated Liver Disease.

Authors:  Gustavo Ayares; Francisco Idalsoaga; Luis A Díaz; Jorge Arnold; Juan P Arab
Journal:  J Clin Exp Hepatol       Date:  2022-02-12

2.  N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review.

Authors:  Sang-Ho Jo
Journal:  Korean Circ J       Date:  2011-12-31       Impact factor: 3.243

3.  Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats.

Authors:  Ahmed Atwa; Rehab Hegazy; Rania Mohsen; Neamat Yassin; Sanaa Kenawy
Journal:  Open Access Maced J Med Sci       Date:  2017-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.